Literature DB >> 8380663

Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.

S Bräutigam1, E Snezhkov, D H Bishop.   

Abstract

The cDNA sequences encoding the VP0, VP3, and VP1 structural proteins of poliovirus type 3 (strain P3/Leon/37) have been individually cloned and used to prepare recombinant baculoviruses based on Autographa californica nuclear polyhedrosis viruses (AcNPV). Expression of the proteins was monitored in virus-infected Spodoptera frugiperda cells. Both the individually expressed VP0 protein and VP0 derived from the complete poliovirus coding region were shown to incorporate myristic acid. A significant improvement in VP0 protein yield was obtained when the amino terminal glycine of VP0 was changed to alanine (VP0/ala), suggesting that the presence of glycine or its myristylation is unfavorable for VP0 expression. Even so, the expression levels of the poliovirus capsid proteins were low by comparison with those obtained for other foreign genes (e.g., lacZ). The reason does not appear to be due to protein instability or, from the studies undertaken with VP0, the sequences that flank the AUG codon. Using recombinant baculoviruses that express VP0, VP1, and VP3 (or VP0/ala, VP1, and VP3), poliovirus-like particles (VLPs) were isolated from infected S. frugiperda cells. Examination by electron microscopy of the VLPs purified by CsCl gradient centrifugation revealed structures corresponding in size, appearance, and antigenicity to those expected for poliovirus procapsids; however, the yields of particles were low when compared to those derived from a construct (AcLeon) that expresses the complete coding region of poliovirus type 3, indicating that procapsid synthesis from the P1 precursor is a more favored route.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380663     DOI: 10.1006/viro.1993.1067

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay.

Authors:  Young-Joon Ko; Kang-Seuk Choi; Jin-Ju Nah; David J Paton; Jae-Ku Oem; Ginette Wilsden; Shien-Young Kang; Nam-In Jo; Joo-Ho Lee; Jae-Hong Kim; Hee-Woo Lee; Jong-Myeong Park
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

2.  Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.

Authors:  Ekaterina G Viktorova; Sunil K Khattar; Diana Kouiavskaia; Majid Laassri; Tatiana Zagorodnyaya; Eugenia Dragunsky; Siba Samal; Konstantin Chumakov; George A Belov
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

3.  Characterization of Coxsackievirus B4 virus-like particles VLP produced by the recombinant baculovirus-insect cell system expressing the major capsid protein.

Authors:  Ikbel Hadj Hassine; Jawhar Gharbi; Bechr Hamrita; Mohammed A Almalki; José Francisco Rodríguez; Manel Ben M'hadheb
Journal:  Mol Biol Rep       Date:  2020-04-02       Impact factor: 2.316

4.  Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization.

Authors:  J C Sáiz; J Cairó; M Medina; D Zuidema; C Abrams; G J Belsham; E Domingo; J M Vlak
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Expression, purification and characterization of enterovirus-71 virus-like particles.

Authors:  Yao-Chi Chung; Jen-Huang Huang; Chia-Wei Lai; Heng-Chun Sheng; Shin-Ru Shih; Mei-Shang Ho; Yu-Chen Hu
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

Review 6.  Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.

Authors:  Maria Tagliamonte; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

7.  Assembly of recombinant Israeli Acute Paralysis Virus capsids.

Authors:  Junyuan Ren; Abigail Cone; Rebecca Willmot; Ian M Jones
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

8.  Increasing Type 1 Poliovirus Capsid Stability by Thermal Selection.

Authors:  Oluwapelumi O Adeyemi; Clare Nicol; Nicola J Stonehouse; David J Rowlands
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

9.  Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity.

Authors:  Claudine Porta; Xiaodong Xu; Silvia Loureiro; Saravanan Paramasivam; Junyuan Ren; Tara Al-Khalil; Alison Burman; Terry Jackson; Graham J Belsham; Stephen Curry; George P Lomonossoff; Satya Parida; David Paton; Yanmin Li; Ginette Wilsden; Nigel Ferris; Ray Owens; Abhay Kotecha; Elizabeth Fry; David I Stuart; Bryan Charleston; Ian M Jones
Journal:  J Virol Methods       Date:  2012-11-19       Impact factor: 2.014

10.  Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids.

Authors:  Ana Clara Mignaqui; Vanesa Ruiz; Sylvie Perret; Gilles St-Laurent; Parminder Singh Chahal; Julia Transfiguracion; Ayelén Sammarruco; Victoria Gnazzo; Yves Durocher; Andrés Wigdorovitz
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.